Circulating plasma cortisol concentrations are not associated with coronary artery disease or peripheral vascular disease

QJM: An International Journal of Medicine

Volumn 102, Issue 7, 2009, Pages 469-475

  Reynolds, R M ^a   Ilyas, B ^a   Price, J F ^b   Fowkes, F G R ^b   Newby, D E ^a   Webb, D J ^a   Walker, B R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOCORTICOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIACYLGLYCEROL;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORTICOSTEROID BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SEX DIFFERENCE; STRESS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 67650434337     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcp057     Document Type: Article

References (37)

1. Ford ES, Capewell S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: Concealed leveling of mortality rates. J Am Coll Cardiol 2007; 50:2128-32.
2. O'Flaherty M, Ford E, Allender S, Scarborough P, Capewell S. Coronary heart disease trends in England and Wales from 1984 to 2004: Concealed levelling of mortality rates among young adults. Heart 2008; 94 178-81.
3. Filipovsky J, Ducimetiere P, Eschwege E, Richard JL, Rosselin G, Claude JR. The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men. J Hypertens 1996; 14:229-35.
4. Phillips DIW, Barker DJP, Fall CHD, Whorwood CB, Seckl JR, Wood PJ, et al. Elevated plasma cortisol concentrations: An explanation for the relationship between low birthweight and adult cardiovascular risk factors. J Clin Endocrinol Metab 1998; 83:757-60.
5. Phillips DIW, Walker BR, Reynolds RM, Flanagan DEH, Wood PJ, Osmond C, et al. Low birthweight and elevated plasma cortisol concentrations in adults from three populations. Hypertension 2000; 35 1301-6.
6. Reynolds RM, Walker BR, Phillips DIW, Sydall HE, Andrew R, Wood PJ, et al. Altered control of cortisol secretion in adult men with low birthweight and cardiovascular risk factors. J Clin Endocrinol Metab 2001; 86:245-50.
7. Rosmond R, Dallman MF, Bjorntorp P. Stress-related cortisol secretion in men: Relationships with abdominal obesity and endocrine, metabolic and haemodynamic abnormalities. J Clin Endocrinol Metab 1998; 83 1853-9.
8. Stolk RP, Lamberts SWJ, de Jong FH, Pols HAP, Grobbee DE. Gender differences in the associations between cortisol and insulin sensitivity in healthy subjects. J Endocrinol 1996; 149:313-8.
9. Walker BR. Abnormal glucocorticoid activity in subjects with risk factors for cardiovascular disease. Endocr Res 1996; 22 701-8.
10. Watt GCM, Harrap SB, Foy CJW, Holton DW, Edwards HV, Davidson HR, et al. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: A four corners approach to the identification of genetic determinants of blood pressure. J Hypertens 1992; 10 473-82.
11. Souverain PC, Berard A, van Staa TP, Cooper C, Leufkens HGM, Walker BR. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population-based case-control study. Heart 2004; 90: 859-65.
12. Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 2004; 141:764-70.
13. Davey Smith G, Ben-Shlomo Y, Beswick A, Yarnell J, Lightman SL, Elwood P. Cortisol, testosterone and coronary heart disease. Prospective evidence from the Caerphilly study. Circulation 2005; 112 332-40.
14. Alevizaki M, Cimponeriu A, Lekakis J, Papamichael C, Chrousos GP. High anticipatory stress plasma cortisol levels and sensitivity to glucocorticoids predict severity of coronary artery disease in subjects undergoing coronary angiography. Metabolism 2007; 56:222-6.
15. Villa AE, Guzman LA, Chen W, Golomb G, Levy RJ, Topol EJ. Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. J Clin Invest 1994; 93:1243-9.
16. Liu X, De Scheerder I, Desmet W. Dexamethasone-eluting stent: An anti-inflammatory approach to inhibit coronary restenosis. Expert Rev Cardiovasc Ther 2004; 2:653-60.
17. Kakio T, Matsumori A, Ohashi N, Yamada T, Nobuhara M, Saito T, et al The effect of hydrocortisone on reducing rates of restenosis and target lesion revascularization after coronary stenting less than 3mm in stent diameter. Intern Med 2003; 42:1084-9.
18. Versaci F, Gaspardone A, Tomai F, Ribichini F, Russo P, Proietti I, et al. Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS study). J Am Coll Cardiol 2002; 40:1935-42.
19. Ilyas B, Dhaun N, Markie D, Stansell P, Goddard J, Newby DE, et al Renal function is associated with arterial stiffness and predicts outcome in patients with coronary artery disease. Q J Med 2008; 102:183-91.
20. Kendrick S, Clarke J. The Scottish record linkage system. Health Bull (Edinb) 1993; 51:72-9.
21. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20:384-92.
22. Price JF, Lee AJ, Fowkes FG. Steroid sex hormones and peripheral arterial disease in the Edinburgh Artery Study. Steroids 1997; 62:789-94.
23. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962; 27 645-58.
24. McConway MG, Chapman RS. Development and evaluation of a simple, direct, solid-phase radioimmunoassay of serum cortisol from readily available reagents. Clin Chim Acta 1986; 158:59-70.
25. Barth JD, Jansen H, Hugenholtz PG, Birkenhager JC. Postheparin lipases, lipids and related hormones in men undergoing coronary arteriography to assess atherosclerosis. Atherosclerosis 1983; 48:235-41.
26. Koertge J, Al-Khalili F, Ahnve S, Janszky I, Svane B, Schenck-Gustafsson K. Cortisol and vital exhaustion in relation to significant coronary artery stenosis in middle-aged women with acute coronary syndrome. Psychoneuroendocrinology 2002; 27:893-906.
27. Troxler RG, Sprague EA, Albanese RA, Fuchs R, Thompson AJ. The association of elevated plasma cortisol and early atherosclerosis as demonstrated by coronary angiography. Atherosclerosis 1977; 26 151-62.
28. Hauner H, Bognar E, Blum A. Body fat distribution and its association with metabolic and hormonal risk factors in women with angiographically assessed coronary artery disease. Evidence for the presence of a metabolic syndrome. Atherosclerosis 1994; 105:209-16.
29. Varma VK, Rushing JT, Ettinger WH Jr. High density lipoprotein cholesterol is associated with serum cortisol in older people. J Am Geriatr Soc 1995; 43:1345-9.
30. Seeman TE, Singer BH, Rowe JW, Horwitz RI, McEwen BS. Price of adaptation - allostatic load and its health consequences. MacArthur studies of successful aging. Arch Intern Med 1997; 157 2259-68.
31. Matthews K, Schwartz J, Cohen S, Seeman T. Diurnal cortisol decline is related to coronary calcification: CARDIA study. Psychosom Med 2006; 68:657-61.
32. Nijm J, Kristenson M, Olsson AG, Jonasson L. Impaired cortisol response to acute stressors in patients with coronary disease. Implications for inflammatory activity. J Intern Med 2007; 262:375-84.
33. Chandola T, Britton A, Brunner E, Hemingway H, Malik M, Kumari M, et al. Work stress and coronary heart disease: What are the mechanisms? Eur Heart J 2008; 29:640-8.
34. Albiger N, Testa RM, Almoto B, Ferrari M, Bilora F, Petrobelli F, et al. Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: Comparison with a population matched for similar cardiovascular risk factors. Horm Metab Res 2006; 38: 405-10.
35. Dekker MJ, Koper JW, van Aken MO, Pols HA, Hofman A, de Jong FH, et al. Salivary cortisol is related to atherosclerosis of carotid arteries. J Clin Endocrinol Metab 2008; 93:3741-7.
36. Travia D, Tosi F, Negri C, Faccini G, Moghetti P, Muggeo M. Sustained therapy with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors does not impair steroidogenesis by adrenals and gonads. J Clin Endocrinol Metab 1995; 80:836-40.
37. Reynolds RM, Fischbacher C, Bhopal R, Byrne CD, White M, Unwin N, et al. Differences in cortisol concentrations in South Asian and European men living in the United Kingdom. Clin Endocrinol 2006; 64:530-4.